Normobaric Hyperoxia

DEVICE4 trials

Sponsors

Capital Medical University, Ji Xunming,MD,PhD, University of Florida

Conditions

Acute Ischemic StrokeNeuroprotectionStroke, AcuteTraumatic Spinal Cord Injuries

Phase 2

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

CompletedNCT04681651

Capital Medical UniversityNeuroprotection, Stroke, Acute

Start: 2021-04-22End: 2023-05-05Updated: 2023-07-06

Treating Spinal Cord Injury With Early Normobaric Hyperoxia

Not yet recruitingNCT07465302

University of FloridaTraumatic Spinal Cord Injuries

Start: 2026-03-01End: 2028-09-30Target: 12Updated: 2026-03-11

Phase 3

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

RecruitingNCT05965687

Ji Xunming,MD,PhDAcute Ischemic Stroke

Start: 2023-08-17End: 2024-10-30Target: 1230Updated: 2024-03-28

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)

RecruitingNCT05965193

Ji Xunming,MD,PhDAcute Ischemic Stroke

Start: 2023-08-17End: 2025-10-30Target: 1230Updated: 2024-03-28

Related Papers

Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.

2025-02-0111 citations